In Vitro Toxicology Testing-Global Market Status and Trend Report 2016-2026

Table of Contents

Chapter 1 Overview of In Vitro Toxicology Testing

• 1.1 Definition of In Vitro Toxicology Testing in This Report
• 1.2 Commercial Types of In Vitro Toxicology Testing
  • 1.2.1 Cell Culture Technology
  • 1.2.2 High-throughput Technology
  • 1.2.3 Cellular Imaging Technology
  • 1.2.4 Toxicogenomics
• 1.3 Downstream Application of In Vitro Toxicology Testing
  • 1.3.1 Pharmaceuticals & Biopharmaceuticals Industry
  • 1.3.2 Cosmetics and Household Products Industry
  • 1.3.3 Food Industry
  • 1.3.4 Chemicals Industry
• 1.4 Development History of In Vitro Toxicology Testing
• 1.5 Market Status and Trend of In Vitro Toxicology Testing 2016-2026
  • 1.5.1 Global In Vitro Toxicology Testing Market Status and Trend 2016-2026
  • 1.5.2 Regional In Vitro Toxicology Testing Market Status and Trend 2016-2026

Chapter 2 Global Market Status and Forecast by Regions

• 2.1 Market Development of In Vitro Toxicology Testing 2016-2021
• 2.2 Production Market of In Vitro Toxicology Testing by Regions
  • 2.2.1 Production Volume of In Vitro Toxicology Testing by Regions
  • 2.2.2 Production Value of In Vitro Toxicology Testing by Regions
• 2.3 Demand Market of In Vitro Toxicology Testing by Regions
• 2.4 Production and Demand Status of In Vitro Toxicology Testing by Regions
  • 2.4.1 Production and Demand Status of In Vitro Toxicology Testing by Regions 2016-2021
  • 2.4.2 Import and Export Status of In Vitro Toxicology Testing by Regions 2016-2021

Chapter 3 Global Market Status and Forecast by Types

• 3.1 Production Volume of In Vitro Toxicology Testing by Types
• 3.2 Production Value of In Vitro Toxicology Testing by Types
• 3.3 Market Forecast of In Vitro Toxicology Testing by Types

Chapter 4 Global Market Status and Forecast by Downstream Industry

• 4.1 Demand Volume of In Vitro Toxicology Testing by Downstream Industry
• 4.2 Market Forecast of In Vitro Toxicology Testing by Downstream Industry

Chapter 5 Market Driving Factor Analysis of In Vitro Toxicology Testing

• 5.1 Global Economy Situation and Trend Overview
• 5.2 In Vitro Toxicology Testing Downstream Industry Situation and Trend Overview

Chapter 6 In Vitro Toxicology Testing Market Competition Status by Major Manufacturers

• 6.1 Production Volume of In Vitro Toxicology Testing by Major Manufacturers
• 6.2 Production Value of In Vitro Toxicology Testing by Major Manufacturers
• 6.3 Basic Information of In Vitro Toxicology Testing by Major Manufacturers
  • 6.3.1 Headquarters Location and Established Time of In Vitro Toxicology Testing Major Manufacturer
  • 6.3.2 Employees and Revenue Level of In Vitro Toxicology Testing Major Manufacturer
• 6.4 Market Competition News and Trend
  • 6.4.1 Merger, Consolidation or Acquisition News
  • 6.4.2 Investment or Disinvestment News
  • 6.4.3 New Product Development and Launch

Chapter 7 In Vitro Toxicology Testing Major Manufacturers Introduction and Market Data

• 7.1 SGS
  • 7.1.1 Company profile
  • 7.1.2 Representative In Vitro Toxicology Testing Product
  • 7.1.3 In Vitro Toxicology Testing Sales, Revenue, Price and Gross Margin of SGS
• 7.2 Covance
  • 7.2.1 Company profile
  • 7.2.2 Representative In Vitro Toxicology Testing Product
  • 7.2.3 In Vitro Toxicology Testing Sales, Revenue, Price and Gross Margin of Covance
• 7.3 Bio-Rad Laboratories
  • 7.3.1 Company profile
  • 7.3.2 Representative In Vitro Toxicology Testing Product
  • 7.3.3 In Vitro Toxicology Testing Sales, Revenue, Price and Gross Margin of Bio-Rad Laboratories
• 7.4 Qiagen
  • 7.4.1 Company profile
  • 7.4.2 Representative In Vitro Toxicology Testing Product
  • 7.4.3 In Vitro Toxicology Testing Sales, Revenue, Price and Gross Margin of Qiagen
• 7.5 GE Healthcare
  • 7.5.1 Company profile
  • 7.5.2 Representative In Vitro Toxicology Testing Product
  • 7.5.3 In Vitro Toxicology Testing Sales, Revenue, Price and Gross Margin of GE Healthcare
• 7.6 Eurofins Scientific
  • 7.6.1 Company profile
  • 7.6.2 Representative In Vitro Toxicology Testing Product
  • 7.6.3 In Vitro Toxicology Testing Sales, Revenue, Price and Gross Margin of Eurofins Scientific
• 7.7 Merck
  • 7.7.1 Company profile
  • 7.7.2 Representative In Vitro Toxicology Testing Product
  • 7.7.3 In Vitro Toxicology Testing Sales, Revenue, Price and Gross Margin of Merck
• 7.8 Thermo Fisher
  • 7.8.1 Company profile
  • 7.8.2 Representative In Vitro Toxicology Testing Product
  • 7.8.3 In Vitro Toxicology Testing Sales, Revenue, Price and Gross Margin of Thermo Fisher
• 7.9 Charles River Laboratories International
  • 7.9.1 Company profile
  • 7.9.2 Representative In Vitro Toxicology Testing Product
  • 7.9.3 In Vitro Toxicology Testing Sales, Revenue, Price and Gross Margin of Charles River Laboratories International
• 7.10 Catalent
  • 7.10.1 Company profile
  • 7.10.2 Representative In Vitro Toxicology Testing Product
  • 7.10.3 In Vitro Toxicology Testing Sales, Revenue, Price and Gross Margin of Catalent
• 7.11 Cyprotex
  • 7.11.1 Company profile
  • 7.11.2 Representative In Vitro Toxicology Testing Product
  • 7.11.3 In Vitro Toxicology Testing Sales, Revenue, Price and Gross Margin of Cyprotex
• 7.12 Promega
  • 7.12.1 Company profile
  • 7.12.2 Representative In Vitro Toxicology Testing Product
  • 7.12.3 In Vitro Toxicology Testing Sales, Revenue, Price and Gross Margin of Promega
• 7.13 Gentronix Limited
  • 7.13.1 Company profile
  • 7.13.2 Representative In Vitro Toxicology Testing Product
  • 7.13.3 In Vitro Toxicology Testing Sales, Revenue, Price and Gross Margin of Gentronix Limited
• 7.14 Ascendance Biotechnology
  • 7.14.1 Company profile
  • 7.14.2 Representative In Vitro Toxicology Testing Product
  • 7.14.3 In Vitro Toxicology Testing Sales, Revenue, Price and Gross Margin of Ascendance Biotechnology
• 7.15 MB Research Laboratories
  • 7.15.1 Company profile
  • 7.15.2 Representative In Vitro Toxicology Testing Product
  • 7.15.3 In Vitro Toxicology Testing Sales, Revenue, Price and Gross Margin of MB Research Laboratories

Chapter 8 Upstream and Downstream Market Analysis of In Vitro Toxicology Testing

• 8.1 Industry Chain of In Vitro Toxicology Testing
• 8.2 Upstream Market and Representative Companies Analysis
• 8.3 Downstream Market and Representative Companies Analysis

Chapter 9 Cost and Gross Margin Analysis of In Vitro Toxicology Testing

• 9.1 Cost Structure Analysis of In Vitro Toxicology Testing
• 9.2 Raw Materials Cost Analysis of In Vitro Toxicology Testing
• 9.3 Labor Cost Analysis of In Vitro Toxicology Testing
• 9.4 Manufacturing Expenses Analysis of In Vitro Toxicology Testing

Chapter 10 Marketing Status Analysis of In Vitro Toxicology Testing

• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
  • 10.1.3 Marketing Channel Development Trend
• 10.2 Market Positioning
  • 10.2.1 Pricing Strategy
  • 10.2.2 Brand Strategy
  • 10.2.3 Target Client
• 10.3 Distributors/Traders List

Chapter 11 Report Conclusion

Chapter 12 Research Methodology and Reference

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources